These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7021448)

  • 1. Multicentre study with viloxazine (Vivalan) in depressed patients.
    Kabes J; Dostal T; Náhunek K; Svestka J; Molcan J; Caplová T; Hynek K; Faltus F; Holland RP
    Int Pharmacopsychiatry; 1980; 15(4):228-39. PubMed ID: 7021448
    [No Abstract]   [Full Text] [Related]  

  • 2. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical trials of viloxazine in depressive states].
    Fontan M; Goudemand M; Pellerin-Millecamps E
    Encephale; 1979; 5(3):243-9. PubMed ID: 385296
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
    Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of Vivalan (viloxazine hydrochloride) with imipramine in the treatment of depression. A double-blind study.
    Santonastaso P; Maistrello I; Battistin L
    Acta Psychiatr Scand; 1979 Aug; 60(2):137-43. PubMed ID: 388987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viloxazine in the treatment of depression: psychophysical measures and clinical response.
    Amin MM; Ban TA; Lehmann HE; Khan P
    Psychopharmacol Bull; 1978 Jan; 14(1):33-5. PubMed ID: 625536
    [No Abstract]   [Full Text] [Related]  

  • 7. Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
    Petrie WM; Ban TA; Wilson WH; Jamieson RC; Guy W
    Int Pharmacopsychiatry; 1982; 17(4):280-6. PubMed ID: 7185772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind trial: vivalan against placebo in depressed elderly patients.
    Von Knorring L
    J Int Med Res; 1980; 8(1):18-21. PubMed ID: 6987113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
    McEvoy JP; Sheridan WF; Stewart WR; Ban TA; Wilson WH; Guy W; Schaffer JD
    Br J Psychiatry; 1980 Nov; 137():440-3. PubMed ID: 7008890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
    Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
    Adv Biochem Psychopharmacol; 1982; 32():369-73. PubMed ID: 7090902
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparative study of viloxazine and imipramine in the treatment of depressive states.
    Elwan O
    J Int Med Res; 1980; 8(1):7-17. PubMed ID: 7358207
    [No Abstract]   [Full Text] [Related]  

  • 13. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.
    Petrie WM; McEvoy JP; Wilson WH; Ban TA; Guy W
    Int Pharmacopsychiatry; 1980; 15(3):193-6. PubMed ID: 7016802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparative study of viloxazine and imipramine (author's transl)].
    Floru L; Tegeler J
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Jul; 12(4):313-20. PubMed ID: 386389
    [No Abstract]   [Full Text] [Related]  

  • 16. A sequential trial of viloxazine (Vivalan) and imipramine in moderately depressed patients.
    Davies B; Joshua S; Burrows G; Poynton C
    Med J Aust; 1977 Apr; 1(15):521-2. PubMed ID: 875786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
    Guy W; Ban TA; McEvoy JP; Petrie WM; Wilson WH; Schaffer JD
    Int Pharmacopsychiatry; 1982; 17(1):36-42. PubMed ID: 7045017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the clinical trial with viloxazine (Vivalan ICI). A part of the multicentre study (author's transl)].
    Kabes J; Dostal T
    Cesk Psychiatr; 1979 Aug; 75(4):225-31. PubMed ID: 393416
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the position of viloxazin in the group of antidepressants (author's transl)].
    Náhunek K; Svestka J; Cesková E; Misurec J
    Cesk Psychiatr; 1978 Feb; 74(1):3-8. PubMed ID: 352549
    [No Abstract]   [Full Text] [Related]  

  • 20. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.